{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:33:53Z","timestamp":1794335633926,"version":"4.9.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T00:00:00Z","timestamp":1656201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Microbes and New Infections"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.nmni.2022.101002","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T13:05:18Z","timestamp":1656594318000},"page":"101002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Campylobacter: Asymptomatic campylobacteriosis and Guillain Barr\u00e9 syndrome in Mexico"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2436-5744","authenticated-orcid":false,"given":"Luis","family":"Del Carpio-Orantes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.nmni.2022.101002_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.17843\/rpmesp.2020.374.5169","article-title":"Agentes infecciosos en muestras biol\u00f3gicas de pacientes con s\u00edndrome de Guillain-Barr\u00e9 en Per\u00fa, 2018-2019","volume":"37","author":"Pachas","year":"2020","journal-title":"Rev Peru Med Exp Salud Publica"},{"issue":"5","key":"10.1016\/j.nmni.2022.101002_bib2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1017\/S0950268813001908","article-title":"The binational outbreak of Guillain-Barr\u00e9 syndrome associated with Campylobacter jejuni infection, Mexico and USA, 2011","volume":"142","author":"Jackson","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.nmni.2022.101002_bib4","doi-asserted-by":"crossref","first-page":"118204","DOI":"10.1016\/j.jns.2021.118204","article-title":"Guillain Barr\u00e9 syndrome during the Zika pandemic from 2016 to 2019 in Veracruz, Mexico","volume":"429","author":"Del Carpio-Orantes","year":"2021","journal-title":"J\u00a0Neurol Sci"},{"issue":"1","key":"10.1016\/j.nmni.2022.101002_bib5","doi-asserted-by":"crossref","first-page":"S410","DOI":"10.1093\/ofid\/ofaa439.910","article-title":"718. Asymptomatic campylobacteriosis as a risk factor for developing acute neurological syndromes in Veracruz, Mexico","volume":"7","author":"Del Carpio-Orantes","year":"2020","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1016\/j.nmni.2022.101002_bib6","series-title":"Report of an expert consultation","year":"2012"}],"container-title":["New Microbes and New Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297522000543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297522000543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:01:17Z","timestamp":1761854477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2052297522000543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":5,"alternative-id":["S2052297522000543"],"URL":"https:\/\/doi.org\/10.1016\/j.nmni.2022.101002","relation":{},"ISSN":["2052-2975"],"issn-type":[{"value":"2052-2975","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Campylobacter: Asymptomatic campylobacteriosis and Guillain Barr\u00e9 syndrome in Mexico","name":"articletitle","label":"Article Title"},{"value":"New Microbes and New Infections","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmni.2022.101002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101002"}}